Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1

Journal of Surgical Oncology

Volumn 88, Issue 2, 2004, Pages 104-107

  Sugiki, Takaaki ^a   Yamamoto, Masakazu ^a   Aruga, Atsushi ^a   Takasaki, Ken ^a   Nakano, Masayuki ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

Author keywords

Hepatocellular carcinoma; Hepatocyte Paraffin 1; Immunohistochemistry; Scirrhous hepatocellular carcinoma

Indexed keywords

CYTOKERATIN 19; EPITHELIAL MEMBRANE ANTIGEN; HEP PAR 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HEPATOCYTE PARAFFIN 1; MUCIN 1; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LIVER CELL CARCINOMA; LIVER HISTOLOGY; LIVER TUMOR; MAJOR CLINICAL STUDY; MODERATELY DIFFERENTIATED LIVER CELL CARCINOMA; POORLY DIFFERENTIATED LIVER CELL CARCINOMA; PRIORITY JOURNAL; SCIRRHOUS LIVER CELL CARCINOMA; STAINING; TUMOR DIFFERENTIATION; WELL DIFFERENTIATED LIVER CELL CARCINOMA; CELL GRANULE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER CELL; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, MONOCLONAL; CARCINOMA, HEPATOCELLULAR; CYTOPLASMIC GRANULES; DIAGNOSIS, DIFFERENTIAL; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING;

EID: 7944227575     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20144     Document Type: Article

References (10)

1. Wennerberg AE, Nalesnik MA, Coleman WB: Hepatocyte paraffin 1: A monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol 1993;143:1050-1054.
2. Leong AS, Sormunen RT, Tsui WM, et al.: Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumors and metastatic carcinoma. Histopathology 1998;33:318-324.
3. Minevini MI, Demetris AJ, Lee RG, et al.: Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997;10:686-692.
4. Siddiqui MT, Saboorian MH, Gokaslan ST, et al.: Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples. Cancer (Cancer Cytopathol) 2002;96:49-52.
5. Ishak KG, Anthony PP, Sobin LH: Histological typing of tumours of the liver, 2nd edn. WHO. New York: Springer-Verlag, 1994.
6. Maitra A, Murakata LA, Albores-Saavedra J: Immunoreactivity for Hepatocyte Paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol 2001;115:689-694.
7. Peiguo GC, Ishizawa S, Emerald W, et al.: Hepatocyte antigen as a marker of hepatocellular carcinoma: An immunohistological comparison to carcinoembryonic antigen, CD10, and alpha-fetoproteon. Am J Surg Pathol 2002;26:978-988.
8. Murakata LA, Ishak KG, Nzeako UC: Clear cell carcinoma of the liver: A comparative immunohistochemical study with renal clear cell carcinoma. Mod Pathol 2000;13:874-881.
9. Wu PC, Fang JW, Lau VK, et al.: Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol 1996;149:1167-1175.
10. Fasano M, Theise ND, Nalesnik M, et al.: Immunohistochemical evaluation of hepatoblastomas with the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anticarcinoembryonic antigen. Mod Pathol 1998;11:934-938.